The Liver Meeting® 2021 - The 72nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Anaheim, CA, United States, 12-15 November 2021

Poster presentations:

• Real-world effectiveness and factors associated with SVR12 in a diverse population of HCV infected persons from four large European cohorts presented by Lars Peters. POSTER
   

18th European AIDS Conference (EACS), October 27-30, 2021, London, United Kingdom

Presentations 

• Recent Abacavir Use and Incident Cardiovascular Disease in Contemporary Treated PLWH within the RESPOND Cohort Consortium  presented by Nadine Josephine Jaschinski on behalf of the RESPOND study group. PRESENTATION
   
• Large inter-country and intra-country differences in the HCV cascades of care in people living with HIV in Russia and Ukraine presented by Olga Fursa on behalf of CARE Study Group. PRESENTATION
   

Poster presentations:

• The association between hepatitis B infection and malignancies in persons living with HIV: results from the EuroSIDA study presented by Amanda Mocroft on behalf of EuroSIDA Study Group. POSTER
   
• Change in body mass index (BMI) and association with clinical outcomes after initiation of contemporary HIV antiretroviral (ARV) regimens in EuroSIDA presented by Wendy Bannister on behalf of EuroSIDA Study Group. POSTER
   
• Incidence and risk factors for suicide, violent/accidental deaths, and substance abuse deaths in persons living with HIV presented by Erich S. Tusch on behalf of EuroSIDA Study Group. POSTER
   
• Use of contraindicated antiretroviral drugs in HIV/HCV coinfected persons receiving HCV treatment with direct acting antivirals results from the EuroSIDA study presented by Myroslava Nikolaichuk on behalf of EuroSIDA Study Group. POSTER
   
• Persistent ALT elevation after 2 years of TDF/TAF-containing ART among persons with HIV/HBV-coinfection: A European multi-cohort collaboration (Euro-B) presented by Lorin Begré on behalf of EuroSIDA Study Group, the Swiss HIV Cohort Study (SHCS) and the French HIV-HBV cohort. POSTER
   
• Incidence of hypertension in people living with HIV receiving InSTI versus other third-drug ART regimens in the RESPOND cohort presented by Dathan Mirembe Byonanebye on behalf of RESPOND Study Group. POSTER
   
• HIV cascade of care in the Eastern European cohort (CARE cohort: Russia, Ukraine, Georgia) presented by Olga Fursa on behalf of CARE Study Group. POSTER
   
• Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality – a multicentre prospective cohort study presented by Christian Kraef on behalf of the TB:HIV study group. POSTER
   

11th IAS Conference on HIV Science, 18-21 July 2021

Presentations:

• Co-morbidities In People Living With HIV: Host- Or HIVAssociated presented by Lene Ryom MD PhD. PRESENTATION
   

Poster presentations:

• Integrase strand transfer inhibitor (INSTI) use and cancer incidence presented by Lauren Greenberg on behalf of the RESPOND Study Group. POSTER

Conference on Retroviruses and Opportunistic Infections, Virtual March 6-10 2021

Pre-recorded presentation:

• Hepatitis C cascade of care in HIV/HCV-coinfected persons in Europe in the DAA era presented by Olga Fursa on behalf of the EuroSIDA Study Group. PRESENTATION
   
• Hepatitis delta-related disease burden in HIV/HBV coinfected presented by Charles Béguelin on behalf of the EuroSIDA Study Group and the Swiss HIV Cohort Study. PRESENTATION
   
• Association between newer antiretrovirals and increase in body mass index RESPOND presented by Loveleen Bansi-Matharu on behalf of the RESPOND Study Group. PRESENTATION
   
• Association between integrase inhibitors (INSTIs) and cardiovascular disease (CVD) presented by Bastian Neesgaard on behalf of the RESPOND Study Group. PRESENTATION